BSE Limited Infuses ₹41.28 Crore in India INX to Strengthen Operations and Stake

Key Highlights

  • BSE Limited invested ₹41.28 crore in India INX via rights issue.
  • Investment made through the Overseas Direct Investment route.
  • BSE Limited’s stake in India INX to rise to 65.27% post-investment.
  • India INX reported ₹3.54 crore turnover in FY25.
  • SEBI approved the investment on August 1, 2025.
  • Allotment completion expected by January 11, 2026.

BSE Limited has infused ₹41.28 crore into its subsidiary, India International Exchange (IFSC) Limited (India INX), by subscribing to a rights issue through the Overseas Direct Investment (ODI) route. The capital infusion aims to support ongoing operations and fund new strategic initiatives of the exchange.

The move follows BSE’s earlier board approval dated August 7, 2025. With this latest investment, BSE Limited’s shareholding in India INX is set to increase to 65.27%, assuming full subscription of the rights issue.

India INX, based in GIFT City, Gandhinagar, Gujarat, is a recognized stock exchange regulated by the International Financial Services Centre Authority (IFSCA). The exchange recorded a turnover of ₹3.54 crore in FY25, compared to ₹3.45 crore in FY24 and ₹4.17 crore in FY23.

The Securities and Exchange Board of India (SEBI) granted approval for the investment through letter SEBI/HO/MRD/RAC2/P/OW/2025/20650/1 dated August 1, 2025. The allotment process is expected to be completed by January 11, 2026.

BSE Limited clarified that the transaction does not fall under the category of related party transactions, as the company has no promoter or promoter group.

Share

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top